Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical trial of RLYB116 for complement-mediated diseases, with its initial ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...

Most people infected with the SARS-CoV-2 virus recover after the acute illness. However, a significant proportion of infected individuals develop long-lasting symptoms with a wide range of ...

During the recent Covid-19 pandemic, the rate of serious illness and death was jarringly high in older populations. Why? Weakening immune systems — as we age, we become more vulnerable to infections, ...

Our immune system protects against disease through a complex network of innate and adaptive components. It includes white blood cells, antibodies, blood marrow and the thymus gland. As well as ...

Scientists generally agree that eukaryotes, the domain of life whose cells contain nuclei and that includes almost all multicellular organisms, originated from a process involving the symbiotic union ...

Quadruple attenuated intracellular Listeria has demonstrated safety and potency in preclinical studies and is set to enter ...

Korea Research Institute of Bioscience and Biotechnology has reported that a pharmaceutical excipient can prime innate immunity and deliver complete survival in mouse models exposed to ...